Share Issues
Historical of Shares’ Issues
Please read this carefully as it applies to all persons who visit this website.
Access to the information and documents on this portion of the website is restricted for regulatory reasons.
This website and the information contained herein are not intended for, and must not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories and possessions, the “United States”), Canada, Australia, South Africa or Japan or jurisdictions in which access may be unlawful, and do not constitute an offer to sell or the solicitation of an offer to acquire, any shares or other securities of Oryzon Genomics, S.A. (the “Company”) in the United States, Canada, Australia, South Africa or Japan or such other jurisdictions where such offer or solicitation would be unlawful.
The shares or other securities of the Company referred to on this website have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered, sold or exercised in the United States absent registration or an applicable exemption from registration thereunder.
This website and the information contained herein are directed in each Member State of the European Economic Area and the United Kingdom (each a “Relevant State”) to persons who are “qualified investors” within the meaning of Article 2(e) of the Prospectus Regulation (“Qualified Investors”). In addition, in the United Kingdom, this website and the information contained herein are directed only at Qualified Investors: (i) who have professional experience in matters relating to investments falling within the definition of “investment professionals” in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (ii) falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "Relevant Persons"). This website and the information contained herein must not be acted on or relied on: (i) in any Relevant State other than the United Kingdom, by persons who are not Qualified Investors; and (ii) in the United Kingdom, by persons who are not Relevant Persons. Any investment or investment activity to which this website and the information contained herein relate is available only to: (i) in any Relevant State other than the United Kingdom, Qualified Investors; and (ii) in the United Kingdom, Relevant Persons and will be engaged in only with such persons. For the purposes of this paragraph, the expression “Prospectus Regulation” means Regulation (EU) 2017/1129.
Access to the information and documents contained on this website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons residing outside of the United States, Canada, Australia, South Africa and Japan who wish to have access to the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.
I therefore certify that:
(1) I am resident and physically present outside the United States, Canada, Australia, South Africa and Japan;
(2) I am not resident or physically present in any Relevant State, or else I am a Qualified Investor;
(3) I am not resident or physically present in the United Kingdom, or else I am a Relevant Person; and
(4) I am resident and physically present outside each of the jurisdictions referred to in clauses (1) through (3) above, and I am authorized to access the information and documents on this website without being subject to any legal restriction and without any further action required by the Company.
I have read, understand and agree to comply with all of the restrictions set forth above.
We regret that, due to regulatory restrictions, we are unable to provide you with access to this section of our website.
Access to this information is limited to certain authorized persons who are resident and physically present in jurisdictions outside the United States, Canada, Australia, South Africa and Japan.
| Official Registration Date | Prospectus Name |
|---|---|
| 25/Jun/2020 | Improvement Universal Registration Document 2019 (in Spanish) Documents incorporated by reference: - Annual Financial Statements, together with the corresponding audit report, and Management Report as of December 31, 2019, which includes as an Annex the Annual Corporate Governance Report for fiscal year 2019 forming an integral part thereof ( link). - Annual Financial Statements, together with the corresponding audit report, and Management Report as of December 31, 2018, which includes as an Annex the Annual Corporate Governance Report for fiscal year 2018 forming an integral part thereof ( link). - Annual Financial Statements, together with the corresponding audit report, and Management Report as of December 31, 2017, which includes as an Annex the Annual Corporate Governance Report for fiscal year 2017 forming an integral part thereof ( link). |
| 26/Jul/2019 | Summary (in Spanish) Summary (admission to trading of 6,666,667 ordinary shares) |
| 26/Jul/2019 | Securities note (in Spanish) Securities note (admission to trading of 6,666,667 ordinary shares) |
| 23/Jul/2019 | Universal Registration Document 2019 (in Spanish) Documents incorporated by reference: - Annual Financial Statements, together with the corresponding audit report, and Management Report as of December 31, 2018, which includes as an Annex the Annual Corporate Governance Report for fiscal year 2018 forming an integral part thereof ( link). - Annual Financial Statements, together with the corresponding audit report, and Management Report as of December 31, 2017, which includes as an Annex the Annual Corporate Governance Report for fiscal year 2017 forming an integral part thereof ( link). - Annual Financial Statements, together with the corresponding audit report, and Management Report as of December 31, 2016, which includes as an Annex the Annual Corporate Governance Report for fiscal year 2016 forming an integral part thereof ( link). |
| 24/Jul/2018 | Continued Prospectus Registration Document |
| 04/Apr/2017 | Note About Shares (in Spanish) |
| 09/Feb/2017 | Continued Prospectus (in Spanish) Registration Document |
| 10/Dec/2015 | Trading Prospectus Prospectus for the company's shares listing registered with the Spanish National Securities Market Commission (CNMV) |